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1. Introduction 
Mesenteric ischemia occurs when perfusion of the visceral organs fails to meet normal 
metabolic requirements. This disorder is categorized as either acute and chronic, based on 
the duration of symptoms. Acute mesenteric ischemia (AMI) occurs rapidly over hours to 
days and frequently leads to acute intestinal infarction requiring resection. 
2. Anatomy of the visceral arteries 
The celiac artery arises from the abdominal aorta just caudal to the diaphragm at the level of 
L1 and is bordered by the median arcuate ligament at the aortic hiatus superiorly and the 
superior border of the pancreas inferiorly.Traditionally, the three branches from this 
common trunk include the left gastric, splenic, and common hepatic arteries. However, 
multiple variations of the true “trifurcation” can exist. Most frequently, the common hepatic 
artery and its branches arise from the SMA or directly from the abdominal aorta (1). 
The SMA arises a few centimeters caudal to the celiac trunk, and its origin is crossed by the 
neck of the pancreas and the splenic vein. 
The IMA is usually located 3 to 4 cm cephalic to the aortic bifurcation, just to the left of 
midline, and usually arises at the level of the third lumbar vertebra. 
2.1 Acute mesenteric ischemia 
2.1.1 Embolism 
The most common cause of AMI is embolization to the SMA. Arterial emboli are responsible 
for 40% to 50% of cases of AMI (2, 3, 4).The proximal source of the embolus is frequently 
intracardiac mural thrombus. Mural thrombus in proximal aneurysms in the thoracic or 
proximal abdominal aorta can also serve as embolic sources. Because the SMA arises at a less 
acute angle from the abdominal aorta compared with the other mesenteric vessels, it appears 
to be the most common final destination for mesenteric emboli. Additionally, such emboli tend 
to lodge several centimeters from the vessel's origin, usually distal to the middle colic artery. 
2.1.2 Arterial thrombosis 
Arterial thrombosis constitutes the next most common cause of AMI and occurs in 20% to 
35% of cases (4, 5). Preexisting atherosclerotic plaque affecting all visceral vessels is the  
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Fig. 1. Anatomy of the visceral arteries  
most common finding. The affected segment of artery is usually its origin at the level of the 
aorta. Patients with acute arterial thrombosis frequently have preexisting symptoms of CMI. 
Acute extension of an aortic dissection can also serve as a mechanism for abrupt mesenteric 
vessel occlusion and thrombosis. The degree of intestinal infarction was significantly greater 
in patients with SMA thrombosis compared with embolus. 
2.1.3 Nonocclusive mesenteric ischemia 
Impaired intestinal perfusion in the absence of thromboembolic occlusion is termed 
nonocclusive mesenteric ischemia (NOMI). Symptomatic patients are frequently found to 
have extensive atherosclerosis, with involvement of all three visceral arteries. However, 
NOMI can also occur in patients without mesenteric arterial occlusive disease (6, 7, 8). 
Visceral ischemia can occur due to low-flow states, especially in conjunction with intestinal 
atherosclerotic disease. NOMI most commonly occurs secondary to cardiac disease, 
particularly severe congestive heart failure (9). 
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2.1.4 Mesenteric venous thrombosis 
MVT constitutes 5% to 15% of all cases of mesenteric ischemia (10). Involvement is usually 
limited to the superior mesenteric vein but can also involve the inferior mesenteric vein and 
portal vein. The extent of bowel ischemia depends largely on the degree of venous 
involvement. Inherited or acquired hypercoagulable diseases, including protein-C and -S 
deficiency, polycythemia vera, antithrombin III deficiency, antiphospholipid antibody 
syndrome, and factor V Leiden mutation, are frequent causes.  
3. Clinical presentation 
3.1 Acute mesenteric ischemia 
The most common symptom of AMI associated with arterial thromboembolic disease is the 
sudden onset of abdominal pain. Lack of collateral flow to the visceral organs leads to a 
more dramatic presentation in AMI, with severe, rapid clinical deterioration. Nausea, 
vomiting, diarrhea, emptying symptoms, and abdominal distention can also occur. Patients 
with NOMI or MVT typically present with a slower clinical course. Frequently, patients 
with NOMI are critically ill, hospitalized, intubated patients who experience a sudden 
deterioration in their clinical condition. 
 
Fig. 2. Acute Mesenteric Ischemia (intraoperative photograph)  
3.2 Chronic mesenteric ischemia 
Postprandial abdominal pain and progressive weight loss are the most common symptoms 
in patients with CMI. Pain is often described as dull and crampy and located in the 
midepigastric region. The course of symptoms can be equated with intestinal claudication. 
Lack of energy leads to failure of the intestinal smooth muscle to relax, which intensifies the 
cramping pain. Pain often occurs 15 to 45 minutes after a meal, and the severity varies 
according to the size and type of meal. Patients typically develop “food fear” and decrease 
their oral intake in anticipation of severe pain after meals. Changes in bowel habits, nausea, 
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and vomiting are less common findings. CMI is believed to be more prevalent in elderly 
women (11). The variable nature of symptoms often makes the diagnosis confusing and can 
result in delayed treatment. The traditional risk factors for atherosclerosis are usually 
present. A heavy smoking history is frequently obtained. The majority of patients also have 
a history of symptomatic manifestations in other vascular beds, most commonly 
cerebrovascular, coronary, and peripheral arteries.  
Physical examination findings are usually nonspecific. Patients are commonly 
undernourished and cachectic.An abdominal bruit can sometimes be auscultated but is not 
always present. Bowel sounds are frequently hyperactive. Guarding and rebound 
tenderness are usually absent. Low prealbumin and albumin levels are often seen, owing to 
the patient's chronic malnourished state. 
4. Diagnostic evaluation 
4.1 Noninvasive evaluation 
Duplex ultrasonography is a useful tool for the early, noninvasive diagnosis of visceral 
ischemic syndromes. Color Doppler scanning can be used to assess the flow velocities and 
resistance index in the splanchnic arteries and their arterial beds, as well to evaluate end-
organ vascularity (12). 
Computed tomography (CT) is an accurate, noninvasive imaging modality for diagnosing 
mesenteric ischemia, CTA diagnosed AMI with a sensitivity of 96% and a specificity of 94%.  
Magnetic resonance angiography (MRA) is useful for diagnosing mesenteric occlusive 
disease. Because MRA takes significantly longer to perform than CTA, its role in evaluating 
patients with AMI is limited.  
4.2 Invasive evaluation 
Conventional angiography remains the “gold standard” in the diagnosis of mesenteric 
ischemia. Anteroposterior and lateral views of the visceral aorta as well as selective 
catheterization of the celiac trunk, SMA, and IMA, provide the most accurate and specific 
localization of stenotic and occlusive lesions. Therapeutic alternatives such as balloon 
angioplasty, stenting, and thrombolysis and percutaneous thrombus extraction can all be 
used to restore luminal visceral blood flow.  
5. Treatment of acute and chronic mesenteric ischemia 
Medical treatment alone is not effective in these patients. Preventive risk factor modification 
helps control the progression of atherosclerosis in the mesenteric circulation as well as other 
vascular beds. Patients with known risks for inheritable hypercoagulable disorders should 
undergo screening and should be treated with systemic anticoagulation if indicated. 
5.1 Endovascular treatment 
Advances in endovascular techniques have greatly expanded the role of percutaneous 
interventions for patients with mesenteric ischemia in recent years. However, endovascular 
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management remains largely limited to patients with CMI. Balloon angioplasty and stenting 
are the most common interventions, and recent reports have documented excellent technical 
results with low patient morbidity.Endovascular therapy should be the treatment of choice 
in high-risk patients with CMI (13, 14, 15, 16). High technical success rates and decreased 
patient morbidity and mortality rates have been reasonably well established in such 
individuals.  
 
Fig. 3. A, Lateral arteriogram of the celiac axis and superior mesenteric artery. Note the mild 
orificial stenosis in the celiac axis and the severe stenosis in the proximal superior 
mesenteric artery. B, Completion study after angioplasty and stenting of the superior 
mesenteric artery stenosis. Note the widely patent superior mesenteric artery, with no 
evidence of stenosis 
5.2 Surgical treatment 
Laparotomy with visceral revascularization can be used to treat patients with both AMI and 
CMI. Patients presenting with signs and symptoms of AMI require urgent abdominal 
exploration, assessment of bowel viability, and revascularization. Several techniques for the 
restoration of intestinal perfusion are available to the vascular surgeon, and familiarity with 
a variety of options is crucial. Before revascularization, large segments of both small and 
large intestine may appear dusky, ischemic, or necrotic.  
5.3 Acute mesenteric ischemia 
5.3.1 SMA embolectomy 
Perfusion of the mesenteric arteries is assessed by palpation and Doppler evaluation. In 
cases in which the obstruction is caused by an embolus, a proximal SMA pulse is often 
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appreciated. Systemic heparinization is established. If the artery feels relatively soft and free 
of atherosclerotic disease, a transverse arteriotomy is performed distal to the area of 
obstruction, and the arterial lumen is assessed for thrombus. Balloon-tipped embolectomy 
catheters are gently passed proximally and distally until no more clot can be removed. Care 
must be taken not to overinflate the balloons and dissect the arterial intima. Distally, 
mesenteric vessels are very thin, and overinflation can result in rupture and intramesenteric 
extravasation. The transverse arteriotomy is then closed primarily with simple interrupted 
Prolene sutures if no endarterectomy is necessary. In cases in which a flow-limiting plaque 
is present, the arteriotomy is converted to a longitudinal one, and a local 
thromboendarterectomy is performed. Patch angioplasty with autogenous vein is the 
preferred method of revascularization owing to potential contamination from concomitant 
bowel resection. The arteriotomy site can also be used for distal anastomosis of an antegrade 
or retrograde bypass if necessary. 
5.4 Chronic mesenteric ischemia 
5.4.1 Transaortic endarterectomy 
Advantages of this operation include removal of atheroma from the aorta and both visceral 
arteries simultaneously. Limitations include the need for extended exposure of the upper 
abdominal aorta via medial visceral rotation and incomplete plaque removal if the atheroma 
extends to the distal artery or if transmural calcification is present. It is suitable for selected 
patients with CMI undergoing elective revascularizaion (17). 
 
Fig. 4. Endarteriektomie of the SMA  
5.5 Antegrade mesenteric bypass 
Reconstruction of the celiac artery and the SMA with a bifurcated prosthetic graft 
originating from the supraceliac aorta. The operation is done through an upper midline or 
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bilateral subcostal incision, depending on the patient’s body habitus and costal cartilage 
flare. Supraceliac-origin grafts are a poor choice in patients with compromised cardiac or 
pulmonary function or those with extensive atherosclerosis or circumferential calcification 
of the supraceliac aorta. In these cases, infrarenal sources of inflow are preferred (18, 19, 21). 
 
Fig. 5. Antegrade aortoceliac–superior mesenteric artery bypass 
5.6 Retrograde mesenteric bypass 
The infrarenal aorta, a prior infrarenal aortic graft, or the iliac artery are excellent inflow 
sources, Two-vessel reconstructions can be performed with retrograde grafts by doing a 
side-to-side anastomosis to the SMA and an end-to-side anastomosis to the common hepatic 
artery. These grafts may be passed on top of or beneath the pancreas and curved in a C 
shape toward the hepatic artery.  
6. Treatment of nonocclusive mesenteric ischemia 
The primary treatment for NOMI is medical, with extensive critical care support and 
prompt arteriography. Operative exploration is reserved for signs of peritonitis that suggest 
the presence of gangrenous bowel that requires excision. Interventional therapies can be 
initiated at the time of the diagnostic arteriogram and are targeted at relieving vasospasm 
using intra-arterial infusions of vasodilator medications. The most common intra-arterial 
agent is phosphodiesterase inhibitor papaverine and prostaglandin (22). Surgical 
exploration is required for all patients who have evidence of any threatened bowel, 
regardless of the underlying cause. The prognosis is poor, despite the absence of organic 
obstruction in the principal arteries. 
www.intechopen.com
 




Fig. 6. Retrograde aortoceliac–superior mesenteric artery bypass 
7. Treatment of mesenteric venous thrombosis 
Initial anticoagulation with heparin is the treatment of choice in patients without peritonitis. 
After initial anticoagulation, continued treatment with low-molecular-weight heparin 
(LMWH) or VKA is advocated. Uncertainties about bowel viability are assessed through 
laparotomy or laparoscopy; it is safer to perform a laparotomy to check for bowel viability 
in patients with signs of peritonitis and rebound tenderness. Endovascular treatment in 
combination with heparin infusion, with or without bowel resection, is an additional 
treatment tool (23, 24, 25, 26, 27). The indications for surgery are peritonitis, severe 
gastrointestinal bleeding, late small bowel perforation, and intestinal stricture; the last is 
often associated with chronic diarrhea. 
7.1 Splanchnic artery aneurysms 
True aneurysms of splanchnic arteries are less common than visceral artery 
pseudoaneurysms, but they remain an important vascular disease. Nearly 22% of these 
present as clinical emergencies, including 8.5% that result in death (28). The pathogenesis 
and natural history of these aneurysms have been reassessed, and in most instances 
redefined, within the past three decades as advances in imaging technology and 
endovascular treatments have begun to influence diagnostic and management strategies. 
Recognition of splanchnic artery aneurysms has increased because of the greater availability 
and widespread use of advanced imaging capabilities such as high-resolution computed 
tomography (CT) scanning, magnetic resonance angiography (MRA), sophisticated 
ultrasonography, and angiography. Selective arteriography remains the most valuable 
examination in planning therapy but noninvasive imaging techniques for diagnosis and 
operative planning are becoming increasingly important.  
Although surgery remains the mainstay of therapy for most splanchnic aneurysms, 
especially in the setting of rupture, many aneurysms (particularly those involving solid 
organs) are now treated with catheter-based interventions. Endovascular approaches are 
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commonly used to control the bleeding that accompanies aneurysm rupture (29), and 
prophylactic treatment of incidentally discovered intact aneurysms has become common 
(particularly those well-collateralized aneurysms that are imbedded within the pancreatic or 
hepatic parenchyma). Embolization has become the preferred treatment in patients at high 
surgical risk or for aneurysms in locations that are difficult to approach surgically.  
 
Arterial Location Incidence of Aneurysms 
Splenic 60.0% 
Hepatic 20.0% 
Superior mesenteric 5.5% 
Celiac 4.0% 
Gastric or gastroepiploic 4.0% 
Jejunal, ileal, or colic 3.0% 
Pancreaticoduodenal or pancreatic 2.0% 
Gastroduodenal 1.5% 
Inferior mesenteric Rare 
Table 1. Incidence of Aneurysms of the Splanchnic Arterial Circulation (30, 31) 
7.2 Splenic artery aneurysm 
The most common of the splanchnic artery aneurysms and account for as many as 60% of 
all reported splanchnic aneurysms (32). The most common clinical risk factors reported in 
association with Splenic Artery Aneurysm are female gender, a history of multiple 
pregnancies, and portal hypertension. A classic calcified ring may be noted in the left 
upper quadrant on a plain x-ray film of the abdomen.the patients may have an abdominal 
bruit, the majority of physical examinations are normal in patients with asymptomatic 
lesions. When rupture occurs, patients usually complain of acute left-sided abdominal 
pain. Shock, abdominal distention, and death can result from free intraperitoneal rupture 
of an Splenic Artery Aneurysm. The overall mortality of ruptured Splenic Artery 
Aneurysm is high (33). 
Splenic aneurysms that have ruptured or are symptomatic require urgent treatment. 
Additionally, aneurysms in pregnant women or those of childbearing age also absolutely 
warrant treatment. Less stringent indications for treatment include aneurysms that are 
noted to be enlarging or those greater than 2 cm in diameter. 
Endovascular exclusion of has been used more recently with general success. Treatment 
options include coil embolization of the splenic artery both proximal and distal to the 
aneurysm itself, thereby effectively “trapping” the lesion (34, 35). 
7.3 Hepatic artery aneurysms 
The hepatic artery is the second most common location for aneurysmal degeneration in the 
splanchnic circulation. The causes are degenerative (“atherosclerotic”), medial degeneration, 
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fibrodysplasia, trauma, infection, biliary diseases and percutaneous or endoscopic 
procedures, polyarteritis nodosa, and congenital disorders. 
 
Fig. 7. Splenic Artery Aneurysm (intraoperative photograph) 
Symptoms can include epigastric or right upper quadrant pain and subsequent 
gastrointestinal hemorrhage and jaundice. Treatment options depend to a large extent on 
the anatomic location and morphology of the Hepatic Artery Aneurysms, underlying 
etiology, and status of the end organ (36, 37, 38, 39). 
7.4 Celiac artery aneurysms 
In contrast to Splenic Artery Aneurysms are Celiac Artery Aneurysms more commonly 
found in men. The causes are medial degeneration or atherosclerotic disease. Less common 
causes include trauma, collagen vascular disease, arterial dissection, anomalous splanchnic 
circulation, and mycotic aneurysms. Open surgical options included aneurysmectomy, 
aneurysmorrhaphy, and ligation (40). 
7.5 Superior mesenteric artery aneurysm 
Most commonly found within the first 5 cm of the artery,, these aneurysms are particularly 
dangerous because complications such as aneurysm rupture, acute thrombosis, or distal 
embolization may jeopardize the entire small bowel. 
Superior Mesenteric Artery Aneurysm associated with an infectious etiology in the majority 
of cases (Mycotic aneurysms). The majority of Superior Mesenteric Artery Aneurysms are 
symptomatic at initial evaluation. Treatment of Superior Mesenteric Artery Aneurysms 
should be considered regardless of size or symptomatology because of the high mortality 
risk associated with potential rupture. treatment must be individualized and based on the 
etiology, size, and anatomic location of the lesion; co-morbid conditions of the patient; and 
the potential morbidity of the proposed procedure (41, 42). 
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